XNYS
DOCS
Market cap10bUSD
Jun 16, Last price
55.96USD
1D
-1.81%
1Q
-11.77%
IPO
-0.11%
Name
Doximity Inc
Chart & Performance
P/E
71.22
P/S
22.11
EPS
0.79
Div Yield, %
—
Shrs. gr., 5y
3.72%
Rev. gr., 5y
40.87%
Revenues
475m
+13.45%
Net income
148m
+30.81%
CFO
184m
+2.50%
Earnings
Aug 06, 2025
Profile
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | |
| Income | ||||||
Revenues | 475,422 13.45% | 419,052 21.98% | ||||
Cost of revenue | 303,608 | 293,944 | ||||
Unusual Expense (Income) | ||||||
NOPBT | 171,814 | 125,108 | ||||
NOPBT Margin | 36.14% | 29.86% | ||||
Operating Taxes | 37,620 | 20,338 | ||||
Tax Rate | 21.90% | 16.26% | ||||
NOPAT | 134,194 | 104,770 | ||||
Net income | 147,582 30.81% | 112,818 -27.11% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | (280,716) | (85,324) | ||||
BB yield | 5.07% | 1.23% | ||||
| Debt | ||||||
Debt current | 2,149 | 3,504 | ||||
Long-term debt | 26,943 | 29,522 | ||||
Deferred revenue | 211 | 198 | ||||
Other long-term liabilities | 18,119 | 17,182 | ||||
Net debt | (733,808) | (807,973) | ||||
| Cash flow | ||||||
Cash from operating activities | 184,096 | 179,602 | ||||
CAPEX | (147) | (6,184) | ||||
Cash from investing activities | 31,186 | (59,923) | ||||
Cash from financing activities | (276,524) | (74,461) | ||||
FCF | 120,757 | 84,174 | ||||
| Balance | ||||||
Cash | 762,900 | 840,999 | ||||
Long term investments | ||||||
Excess cash | 739,129 | 820,046 | ||||
Stockholders' equity | 77,512 | 203,966 | ||||
Invested Capital | 856,761 | 789,987 | ||||
ROIC | 16.30% | 23.64% | ||||
ROCE | 18.39% | 12.50% | ||||
| EV | ||||||
Common stock shares outstanding | 205,734 | 213,425 | ||||
Price | 26.91 -16.89% | 32.38 -37.84% | ||||
Market cap | 5,536,302 -19.89% | 6,910,702 -30.62% | ||||
EV | 4,802,494 | 6,102,728 | ||||
EBITDA | 182,079 | 135,391 | ||||
EV/EBITDA | 26.38 | 45.07 | ||||
Interest | ||||||
Interest/NOPBT | ||||||